Coronavirus disease 2019 (COVID-19) is a current global pandemic. The case number has increased since December 31, 2019. It has been reported that COVID-19 patients have been giving pain complaints, one of which is muscular pain. Other types of pain that have also been reported by COVID-19 patients are joint pain, stomach pain, and testicular pain. Neuropathic pain is the rarest case among others. COVID-19 mechanisms in the nerve and musculoskeletal damage are believed to be caused by the expression and distribution of angiotensin-converting enzyme 2 (ACE-2). Patients with pain, especially neuropathic pain, normally do not respond well to various therapies, and experience psychiatric disorders such as depression, which leads to a decrease in the patient’s quality of life. Important considerations for health professionals in terms of pain management during this pandemic include ensuring treatment continuity, painkillers, utilization of telemedicine, biopsychosocial management approach, and modifying therapy needs to reduce the risks of COVID-19 complications.

中文翻译：

---

作为 COVID-19 感染的临床表现的疼痛及其在大流行时期的管理：文献综述

2019 年冠状病毒病 (COVID-19) 是当前的全球流行病。自2019年12月31日以来，病例数有所增加。据报道，COVID-19患者一直主诉疼痛，其中之一是肌肉疼痛。COVID-19 患者还报告了其他类型的疼痛，包括关节痛、胃痛和睾丸痛。神经性疼痛是其中最罕见的病例。COVID-19 神经和肌肉骨骼损伤的机制被认为是由血管紧张素转换酶 2 (ACE-2) 的表达和分布引起的。患有疼痛，尤其是神经性疼痛的患者通常对各种治疗反应不佳，并且会出现抑郁等精神疾病，从而导致患者的生活质量下降。在这次大流行期间，卫生专业人员在疼痛管理方面的重要考虑因素包括确保治疗的连续性、止痛药、远程医疗的利用、生物心理社会管理方法以及调整治疗需求以降低 COVID-19 并发症的风险。